Aaron Pelta
Corporate Officer/Principal bei MORPHIC HOLDING, INC.
Aktive Positionen von Aaron Pelta
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MORPHIC HOLDING, INC. | Corporate Officer/Principal | 01.01.2019 | - |
Karriereverlauf von Aaron Pelta
Ehemalige bekannte Positionen von Aaron Pelta
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| X4 Pharmaceuticals (Austria) GmbH | Corporate Officer/Principal | 01.08.2016 | 01.03.2019 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 18.06.2015 | 01.11.2015 |
Ausbildung von Aaron Pelta
| Tufts University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
| Österreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| X4 Pharmaceuticals (Austria) GmbH |
- Börse
- Insiders
- Aaron Pelta
- Erfahrung
